House of Delegates today passed the Endocrine Society's resolution to improve access to anti-obesity medications.

The benefits consultant Mercer has said that 44% of U.S. companies with 500 or more employees covered obesity drugs last year. Medicare does pay for drugs like Wegovy for patients who have heart ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Pursuing the worthy goal of reforming drug pricing requires a more radical change to the pharmaceutical industry.

Thousands of New York residents are waiting for a kidney transplant, and a long-delayed state program could soon spur more ...

China, which makes the overwhelming number of polysilicate panels, also happens to be a strategic competitor against the West ...

Leaders of hundreds of public healthcare companies are in South Florida this week, talking up their innovations and financial ...

A new study published in the journal of BMC Nephrology revealed that kidney disease (KD) caused by an infection with the ...

Conflicting recommendations from Trump administration health officials have left health experts, vaccine makers and insurers ...

California's proposed budget cuts to Medicaid/Medi-Cal could exacerbate the obesity crisis, particularly in Black and Brown ...

Want a COVID-19 vaccination this fall? For many Americans, it’s not clear how easy it will be to get one — and some doctors already see signs of trouble. Health Secretary Robert F. Kennedy Jr., ...

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...